Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31196527 | 0.76 | SUCNR1 (0.43) | KDM4ETTRSMN1; SMN2 | |
| SCHEMBL9514859 | 0.76 | SUCNR1 (0.43) | KDM4ETTRSMN1; SMN2 | |
| SCHEMBL350769 | 0.76 | SUCNR1 (0.43) | KDM4ETTRSMN1; SMN2 | |
| SCHEMBL9516478 | 0.76 | SUCNR1 (0.43) | KDM4ETTRSMN1; SMN2 | |
| SCHEMBL9516583 | 0.72 | — | — | |
| SCHEMBL9516453 | 0.72 | — | — | |
| SCHEMBL4640334 | 0.70 | — | — | |
| SCHEMBL840269 | 0.70 | — | — | |
| SCHEMBL28863675 | 0.70 | EPHX1 (0.37) | GAA | |
| Dioxane SCHEMBL21066036 | 0.70 | ACHE (0.54) | KDM4ETTRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6818778-B2 | HYDROLYSIS OF OCTAETHYL(-)-(18-CROWN-6)-2,3,11,12-TETRACARBOXAMIDE OBTAINED BY CONDENSATION OF N,N,N',N'-TETRAALKYL-D-TARTARAMIDE WITH DIHALO- OR DISULFONYLOXY- DIETHYL ETHER | RSTECH CO., LTD. (KR) | 2004-11-16 | — | — | US | claimed |
| US-20040044231-A1 | Process for preparing (-)-(18-crown-6)-2,3,11,12-tetracarboxylic acid, and (-)-chiral stationary phases for resolution of racemic compounds using the same | RSTECH CO., LTD. (KR) | 2004-03-04 | — | — | US | claimed |
| US-6818778-B2 | HYDROLYSIS OF OCTAETHYL(-)-(18-CROWN-6)-2,3,11,12-TETRACARBOXAMIDE OBTAINED BY CONDENSATION OF N,N,N',N'-TETRAALKYL-D-TARTARAMIDE WITH DIHALO- OR DISULFONYLOXY- DIETHYL ETHER | RSTECH CO., LTD. (KR) | 2004-11-16 | — | — | US | disclosed |
| US-20040044231-A1 | Process for preparing (-)-(18-crown-6)-2,3,11,12-tetracarboxylic acid, and (-)-chiral stationary phases for resolution of racemic compounds using the same | RSTECH CO., LTD. (KR) | 2004-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044231-A1 | Process for preparing (-)-(18-crown-6)-2,3,11,12-tetracarboxylic acid, and (-)-chiral stationary phases for resolution of racemic compounds using the same | CCR6, CCR1, CCR9 | KDM4E 3161/4885GAA 3703/4885TTR 991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.